Search results
Results From The WOW.Com Content Network
Multiple endocrine neoplasia, type 2, also called MEN 2, is a rare condition. It causes tumors in the thyroid and parathyroid glands, adrenal glands, lips, mouth, eyes and digestive tract.
WHAT IS MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2)? MEN 2 (Multiple Endocrine Neoplasia Syndrome type 2) is a group of diseases including a type of thyroid cancer called Medullary Thyroid Cancer (MTC). MEN2 is due to a change (mutation) in a gene called RET.
Multiple endocrine neoplasia type 2 (also known as " Pheochromocytoma (codons 630 and 634) and amyloid producing medullary thyroid carcinoma", [1] "PTC syndrome," [1] and "Sipple syndrome" [1]) is a group of medical disorders associated with tumors of the endocrine system. The tumors may be benign or malignant (cancer).
Multiple endocrine neoplasia type 2 (MEN2): This is a genetic polyglandular (multiple glands) cancer syndrome. People with MEN2 will develop medullary thyroid cancer (carcinoma) and have an increased risk of developing other tumors that affect other glands in the endocrine system.
Diagnosis. To diagnose multiple endocrine neoplasia, type 2, also called MEN 2, your health care provider will do a physical exam. They will look at your medical history and family history. They also will do genetic testing to see if you have a gene change that causes MEN 2.
Multiple endocrine neoplasia type 2 (MEN2), also known as Sipple syndrome, is a group of rare familial cancer syndromes involving multiple endocrine organs, most commonly thyroid, adrenal glands, and parathyroid.
Multiple endocrine neoplasia (MEN) syndromes are inherited genetic disorders that cause endocrine (gland) tumors. Endocrine surgeon Lilah Morris-Wiseman, M.D., explains the diagnosis, causes and treatment for multiple endocrine neoplasia.
Multiple endocrine neoplasia (abbreviated MEN) is a condition which encompasses several distinct syndromes featuring tumors of endocrine glands, each with its own characteristic pattern. In some cases, the tumors are malignant, in others, benign.
The endocrine disorders observed in multiple endocrine neoplasia type 2 (MEN2) are: medullary thyroid carcinoma (MTC) and/or its precursor, C-cell hyperplasia (CCH); pheochromocytoma; and parathyroid adenoma or hyperplasia.
Multiple endocrine neoplasia type 2 is a hereditary cancer syndrome associated with thyroid cancer, adrenal gland tumor, and abnormal growth of endocrine tissues.